Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy
- 1 April 2000
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 14 (4) , 463-469
- https://doi.org/10.1046/j.1365-2036.2000.00713.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trialsGastroenterology, 1999
- Interferon-α plus ribavirin in chronic hepatitis C resistant to previous interferon-α course: results of a randomized multicenter trialPublished by Elsevier ,1999
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Therapy of hepatitis C: Re-treatment with alpha interferonHepatology, 1997
- Epidemiology of hepatitis CHepatology, 1997
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Early indicators of prognosis in fulmitant hepatic failure: an assessment of the King's criteriaJournal of Hepatology, 1997
- Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyteJournal of Hepatology, 1995
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981